GlassScriptPhysician profile
Mark J Meyer
NPI 1124263603
$7,208.73
in general payments reported to CMS, 2019-2025
15 companies · $455 in 2025
The $455 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $170 · 2020: $61.62 · 2021: $84.60 · 2022: $266 · 2023: $4,266 · 2024: $1,907 · 2025: $455.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $4,028 · Food and Beverage: $1,326 · Travel and Lodging: $1,274.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $4,027.71 |
| Food and Beverage | $1,325.84 |
| Travel and Lodging | $1,273.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,884.87 | 2019-2025 | Ion, Da Vinci Surgical System |
| Astrazeneca Pharmaceuticals LP | $325.13 | 2021-2025 | Imfinzi, Tagrisso |
| Lsi Solutions INC | $178.14 | 2022-2023 | Ti Knot |
| Ambu INC. | $145.06 | 2021-2024 | |
| Bard Access Systems, INC. | $140.48 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $121.84 | 2025 | Exparel |
| Surmodics, INC. | $118.99 | 2024 | Pounce Thrombectomy, Sublime 014 Rx Pta Balloon Dilatation Catheter, Pounce Thrombectomy System |
| Regeneron Healthcare Solutions, INC. | $101.80 | 2023 | Libtayo |
| Medtronic, INC. | $56.71 | 2021-2023 | Illumisite |
| Atricure, INC. | $42.15 | 2023 | |
| Veran Medical Technologies, INC. | $29.66 | 2020-2021 | |
| Davol INC. | $17.74 | 2020 | |
| Bard Peripheral Vascular, INC. | $16.62 | 2020 | |
| Kls-Martin L.P. | $14.83 | 2023 | |
| Boston Scientific Corporation | $14.71 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Meyer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.